claim – cannabis.co.nz

July 13, 20238, analysis, analytics, business, Business Analysis, candy, cannabis, cbd, claim, compliance, consumer, copycat, cure, Delta, delta 8, drug, Edibles & Processing, FDA, Federal, food, FTC, government, growing, Health, industry, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, marketing, medical, medicine, product, regulation, regulations, regulatory, retail, safety, snack, state, test, thc, unsub, warning

FDA, FTC Issue Warnings to Delta 8 Copycat Cannabis Companies

Last week, the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) sent out warning letters to six different […]

March 30, 2023analysis, analytics, announcement, Arnold & Porter, business, Business Analysis, cannabis, cbd, civil, claim, compliance, consumer, contaminate, contamination, delta 8, Edibles & Processing, FDA, Federal, government, industry, lab, laboratories, laboratory, labs, law, lawsuit, legal, legalization, legalize, legislation, letter, liability, liable, market, Operations, product, Product Development, Quality, recall, recreational, regulation, regulatory, retail, risk, safety, state, suit, test, Testing, thc, warning

Product Liability in the Cannabis Industry: Insights From 2022 & Looking Forward

In 2022, product liability lawsuits in the cannabis/cannabidiol (CBD) industry continued to focus on levels of THC and the psychoactive ingredient in […]

January 24, 2023analysis, analytics, banking, business, Business Analysis, cannabis, cash, cbd, claim, commercial, compensation, compliance, consumer, cover, coverage, CRB, crop, dispensaries, Dispensaries & Retail, dispensary, Federal, general, government, growing, industry, inland, insurance, insure, law, legal, legalization, legalize, legislation, liabilities, liability, license, management, marijuana, marine, market, medical, medicine, Operations, party, product, property, Quality, recreational, regulation, regulations, regulatory, retail, retailer, risk, safe, safety, shop, state, thc, third, worker

A Guide to Dispensary Insurance

As a business owner, insurance is always a must. If you are interested in entering into the cannabis industry or you already […]

September 30, 2022analysis, analytics, bad actors, batch, business, cannabinoid, cannabis, cbd, CEO, certificate of analysis, CGMP, claim, COA, compliance, composition, consumer, contents, CV Sciences, dietary, extraction, FDA, Federal, GMP, good manufacturing practices, government, growing, ID, identity, industry, ingredient, Joseph Dowling, lab, label, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, lot, marijuana, market, medical, medicine, number, packaging, potency, product, purity, Quality, regulation, regulations, regulatory, retail, safety, serving, size, state, strength, Testing, thc, unsubstantiated

Bad Actors in CBD: How to Distinguish Quality Products From the Rest

The success of reputable cannabis and CBD brands has inspired an influx of inexperienced and disreputable competitors in the market. These so-called […]

July 7, 2022analysis, analytics, broker, business, Business Analysis, california, cannabis, claim, compliance, consume, consumer, consumption, cover, covered, Dispensaries & Retail, dispensary, government, growing, holder, industry, insurance, insure, law, legal, legalization, legalize, legislation, liability, liable, license, loss, lounge, manage, management, marijuana, market, medical, Operations, overserved, overserving, policy, product, Quality, recreational, regulation, regulations, regulatory, retail, risk, safety, state, sued, thc

New Insurance Risks as Cannabis Lounges Open Across the US

In a growing number of communities around the U.S., new cannabis lounges are offering a social setting where guests can openly use […]

May 5, 20228, analysis, analytics, business, cannabidiol, cannabis, cbd, claim, compliance, consumer, cure, Delta, delta-8 THC, delta-8-tetrahydrocannabinol, delta-9 tetrahydrocannabinol, delta-9-THC, Dispensaries & Retail, drug, Edibles & Processing, FD&C act, FDA, Federal, government, growing, illegal, industry, lab, label, laboratories, laboratory, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, marketing, medical, medicine, misbranded, prevent, product, Quality, recreational, regulation, regulations, regulatory, retail, safety, state, test, Testing, thc, treat, unapproved, update, violate, violation, warning

FDA Issues First Warning Letters for Delta-8 THC

In an unprecedented move, the U.S. Food & Drug Administration (FDA) has issued warning letters today to companies selling products containing delta-8 […]

April 20, 2022action, analysis, analytics, approval, approved, business, Business Analysis, cannabidiol, cannabis, cbd, claim, compliance, Concentrates & Extracts, consumer, Coronavirus, COVID, COVID-19, cultivation, drug, Edibles & Processing, enforcement, extraction, farm bill, FD&C act, FDA, Federal, government, growing, Health, industry, lab, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, medical, medicine, New, product, Product Development, Quality, regulation, regulations, regulatory, research, retail, safety, state, test, Testing, thc, threaten, U.S. Food and Drug Administration, unapproved, unsubstantiated, warning, wellness

FDA Warning Letters: Stop Claiming CBD Prevents COVID

Once again, the U.S. Food and Drug Administration (FDA) has issued a number of warning letters to companies selling hemp-derived cannabidiol (CBD) […]